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Background: SNAP-25 protein is contributory to plasma membrane and synaptic vesicle fusions that are critical
points in neurotransmission. SNAP-25 gene is associated with behavioral symptoms, personality and psychological
disorders. In addition, SNAP-25 protein can be related to different neurotransmitter functions due to its association
with vesicle membrane transition and fusion. This is important because neurologic, cognitive, and psychologic
disorders in fibromyalgia syndrome (FMS) can be related to this function. This relationship may be enlightening
for etiopathogenesis of FMS and treatment approaches. We aimed to study a SNAP-25 gene polymorphism, which
is related to many psychiatric diseases, and FMS association in this prospective study.
Methods: We included 71 patients who were diagnosed according to new criteria and 57 matched healthy women in
this study. Both groups were evaluated regarding age, height, weight, BMI, education level, marital and occupational
status. A new diagnosis of FMS was made from criteria scoring, SF-36, Beck depression scale, and VAS that were applied
to the patient group. SNAP-25 gene polymorphism and disease activity score correlations were compared.
Results: Mean age was 38±5,196 and 38.12±4.939 in patient and control groups, respectively (p=0.542). No significant
difference was found between groups regarding age, height, weight, BMI, education level, marital or occupational
status (p > 0.05). Ddel T/C genotype was significantly higher in the patient group (p = 0.009). MnlI gene polymorphism
did not show a correlation with any score whereas a significant correlation was found between Ddel T/C genotype and
Beck depression scale and VAS score (p < 0.05).
Conclusion: FMS etiopathogenesis is not clearly known. Numerous neurologic, cognitive and psychological disorders
were found during studies looking at cause. Our study showed increased SNAP-25 Ddel T/C genotype in FMS patients
compared to the control group, which is related to behavioral symptoms, personality and psychological disorders in
FMS patients.
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Fibromyalgia syndrome (FMS) is a non-inflammatory
rheumatologic disease characterized by widespread mus-
culoskeletal pain, lethargy and tenderness without a def-
inite cause [1]. FMS diagnosis is used for heterogeneous
pathological states including anxiety disorders, depres-
sion, lethargy, sleep disorders, and gastrointestinal sys-
tem symptoms with widespread pain [2]. One of the* Correspondence: drayseayan@yahoo.com.tr
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unless otherwise stated.reasons that FMS is thought to be such a heterogeneous
disease may be due to concurrent psychological disor-
ders. Indeed, psychiatric symptoms are very common in
this syndrome, and they influence the course of the dis-
ease [3,4]. FMS patients are reported to have increased
depression, anxiety and bipolar disorder comorbidities
[3,5]. Several studies determined disorders in personality
inventory profiles based on the thought that some person-
ality and mood disorders might predispose to FMS [6-8].
Dopamine is an important mediator in both psycho-
pathological incidents and pain conduction. Dopamine
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ism is found to be relevant to FMS personality profile [10].
SNAP-25 protein is contributory to plasma membrane
and synaptic vesicle [11]. SNAP-25 forms complexes
with synaptobrevin in synaptic vesicles and with syn-
taxin in the plasma membrane [11]. In simple terms,
SNAP-25 protein is critical in neurotransmission for fu-
sion of plasma membrane and synaptic vesicle. Several
studies investigated the relationship between SNAP-25
gene polymorphism and personality disorders, schizo-
phrenia, and attention deficit and hyperactivity disorder;
these studies reported that the SNAP-25 gene might in-
fluence development of these disorders [12-17]. Further-
more, SNAP-25 protein might be relevant to other
different neurotransmitters due to its involvement in
vesicle membrane transition and fusion. This is import-
ant because it can be the main reason behind neuro-
logical, cognitive, psychological disorders in FMS. If
such a relationship exists, it will be enlightening for
etiopathogenesis of FMS and treatment approaches. We
aimed to evaluate the SNAP-25 gene (MnlI = rs3746544
and DdeI = rs1051312) polymorphism, which is related
to many psychiatric diseases, and FMS association in
this prospective study.Patients and methods
Patients and evaluation
We included 71 female patients diagnosed with ACR
2010 fibromyalgia diagnosis criteria and 57 age-matched
healthy females in the study. Patients and healthy volun-
teers were informed about the genetic evaluation and in-
formed consent was taken. Blood (10 cc) was taken into
EDTA tubes from both the patient and control groups
and stored at −20°C. FMS new diagnosis criteria scoring
(ACR 2010), VAS, SF-36, and Beck depression scale were
applied to the patient group. SNAP-25 gene polymorph-
ism prevalence and SNAP-25 polymorphism with dis-
ease activation association were compared. The Local
ethics council of Pamukkale University Clinical Research
Ethics Committee approved the study. Patient consent
was obtained for this study.Tools
A sociodemographic information form was developed by
the researchers and includes patient’s age, sex, education,
socioeconomic status, settlement, marital status and dis-
ease period. The Beck depression scale (BDS) was used
for determining the risk for depression, levels of depres-
sive symptoms and difference of intensity. It was devel-
oped by Beck et al. and adapted to Turkish by Hisli
(Hisli 1989). The VAS consists of 3 parts for measuring
pain. The scale was adapted to Turkish and used in nu-
merous studies. The SF-36 scale to determine quality oflife was subjected to validity and reliability testing for its
use in Turkish.
Molecular analysis
Genetic evaluation was done in our university’s Medical
Genetics Department. Patient and control genomic DNA
was isolated from peripheral blood by a DNA Extraction
Kit. The SNAP-25 genes MnlI (rs3746544) and DdeI
(rs1051312) polymorphisms are on the 8th exon (For-
ward 5′- TTC TCC TCC AAA TGC TGT CG-3′ and
Reverse 5′- CCA CCG AGG AGA GAA AAT G-3′ pri-
mary series were used to replicate the UTR region).
In addition to these primer series, we also used 10X
PCR Buffer, 5 μl dNTP mix consisting of 0.2 mM of
every nucleotide and Taq polymerase enzyme. PCR reac-
tion conditions were 95 degrees C for 2 minutes of de-
naturation followed by 95 degrees C for 45 seconds, 58
degrees C for 1 min, 72 degrees C for 2 minutes of 35 cy-
cles and final elongation at 72 degrees C for 7 minutes.
10UDdel and 10UMnlI enzymeswere added separately
to obtained 261 bp PCR products and this was incubated
for 14 hours at 37°C for cutting. 3.5% Ultra pure agorose
jelly was prepared for separating fragments after cutting.
Later, PCR products were subjected to 40–50 minutes of
electrophoresis and fragmented. After electrophoresis,
the allele band series expected forDdel polymorphism: for
Tallele: 261 bp cut band, for C allele: 228 bp and 33 bp two
separate bands. The allele band series expected for MnlI
polymorphism: for T allele: 256 bp and 5 bp two separate
bands, for G allele: 210 bp, 46 bp and 5 bp three separate
bands.
Statistical analysis
For statistical analysis SPSS version 20 was used. De-
scriptive statistics were given as mean, standard devi-
ation and percentage. Out study’s confidence interval
was 95%. Intergroup significance was evaluated with Chi
square test for qualitative data and Mann–Whitney U
test for quantitative data. Quantitative data relationships
were evaluated with Spearman correlation test. Non
parametric variance analysis was done between genetic
polymorphisms. p < 0.05 was considered as significant.
Results
Mean age was 38±5,196 and 38.12±4.939 in patient and
control groups, respectively (p=0.542). No significant
difference was found between the groups regarding age,
height, weight, BMI, education, settlement, marital or
occupational status (p > 0.05) (Table 1). We determined
MnlI gene polymorphism for TT genotype in 30 (42.3%),
TG genotype in 34 (47.9%) and GG genotype in 7 (9.9%)
patients. Control group had TT genotype in 27 (47.4%),
TG genotype in 19 (33.3%) and GG genotype in 11
(19.3) patients. Dde1 genotype variance in patient group
Table 1 Demographic findings of patient and control
groups
Parameter Patient (n=71) Control (n=57) p
Age 38±5,196 38.12±4.939 0.542
Number of labor 2.01±0.902 1.96±0.566 0.721
Number of children 1.97±0.828 1.91±0.576 0.646
Settlement n (%)
Urban 57 (80.3) 45 (75) 0.536
Rural 14 (19.7) 15 (25)
Marital status n (%)
Married 69 (97.2) 56 (98.25) 0.398
Single 2 (2.8) 1 (1.75)
Occupation n (%)
Working 21 (29.57) 17 (29.82) 0.703
Not working 50 (70.43) 40 (70.18)
Table 3 Fibromyalgia new diagnostic criteria, VAS, Beck
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in 40 (56.3%), TC genotype in 17 (29.8%) and CC geno-
type in 4 (7%). Intergroup SNAP-25 Mnl1 polymorphism
variance was not significantly different (Table 2). Dde1
polymorphism variance between groups showed signifi-
cant difference (p = 0.009). To determine the reason be-
hind this significance, separate match evaluation was
applied and TC genotype was discovered to be the rea-
son. Patient and control groups Mnl1 and Dde1 poly-
morphism variance is given in Table 2.
We evaluated fibromyalgia new diagnosis criteria and
their subscores, Beck depression scale, visual analogue
scale (VAS), short form-36 (SF-36) subparameter scores
(Table 3). Non parametric variance analyses between
genetic polymorphisms were applied. When evaluated
for Mnl1 polymorphism individuals for all three (TT,
TG, GG) genotypes, VAS, BDS and SF-36 did not show
significant differences (p > 0.05). When evaluated for
Dde1 polymorphism individuals for all three (TT, TC,
CC) genotypes, no significant difference was found for
TT and CC individuals; however, TC genotype individ-
uals were significantly higher for BDS (p = 0.045) andTable 2 Mnl1 and Dde1 polymorphism variance in
patient and control groups
Patient n (%) Control n (%) p
Mnl1 gene
TT 30 (42.3) 27 (47.4) 0.149
TG 34 (47.9) 19 (33.3)
GG 7 (9.9) 11 (19.3)
Dde1 gene
TT 29 (40.8) 36 (63.2) 0.009
TC 40 (56.3) 17 (29.8)
CC 2 (2.8) 4 (7)VAS scores (p = 0.033) (Table 4). This difference was sig-
nificant after Bonferoni correction between the groups.
Discussion
The etiopathogenesis of FMS, which is characterized by
widespread musculoskeletal pain and tenderness, is not
clearly understood. FMS, chronic lethargy syndrome,
irritable intestine syndrome, tension type headache,
and myofacial pain syndrome are parts of central
sensitization syndromes. Every one of these syndromes
overlaps with FMS. One common feature of these syn-
dromes is increased central neuron stimulation through
various synaptic and neurotransmitter/neurochemical
activities without structural pathology. This, however, is
characterized by increased sensitivity to pressure and
touch. Many factors contribute to central sensitization
syndrome. These include pain, lethargy, sleep disorder,
sensitivity to several stimuli, and psychosocial problems.
For the past several years, environmental as well as
genetic conditions are blamed for FMS and related
functional somatic disorders such as irritable intestineTable 4 VAS and BDI scores according to the presence TC
genotypes
Parameter All patients TC (+) TC (−) p
BDS 16.77±10.6 17.6±11 15.18±10 0.045
VAS 85.04±12.629 86.41±12.14 83.14±11.83 0.033
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[18-20]. Several studies tried to explain the etiopatho-
genesis of fibromyalgia syndrome. These studies showed
that serum and central nervous system serotonin and its
metabolite levels are low, and serotonin transport vel-
ocity in cerebrospinal fluid is slow. For this reason, the
serotonin transport gene region has been brought to
attention. Offenbaecher et al. reported that the S/S
genotype is increased in FMS patients when compared
to healthy subjects [21].
Dopamine is another molecule that is generating re-
search interest, which has a role in both psychopatho-
logic incidents and pain transport. Studies determined
both dopamine levels and dopamine receptor gene poly-
morphisms and FMS [9,10,22,23].
It is known that psychiatric disorders, especially de-
pression and anxiety disorder are quite common in FMS
patients [3]. Several studies reported depression preva-
lence in FMS between 20% and 80% [3,4,7]. It is
reported that FMS patients have difficulty in both under-
standing their own feelings and coping with emotions.
Several studies determined disorders in personality in-
ventory profiles based on the thought that some person-
ality and mood disorders might predispose to FMS.
When the personality inventory of patients was evalu-
ated, hypochondriasis, hysteria, paranoia, and depression
scales were found to be higher than control groups
[6-8]. Studies indicated that low ability to cope with
everyday problems can trigger FMS or can increase
symptom intensity [6,8]. As a result, some psychiatric
disorders are more prevalent in FMS, and some person-
ality and mood features can predispose to FMS
development.
Nevertheless, the relationship between these situations
and FMS is not clearly known. Psychiatric disorders are
increased in FMS and are relevant to symptom intensity
[4,7]. Some personality and mood features can predis-
pose to FMS, in addition to these features revealing
themselves as a result of stress for coping with pain
[24,25].
There can be common pathophysiological features
between FMS and psychiatric disorders and personali-
ties. Dopamine and serotonin mediated neurotransmitter
transport can be among these common biological factors
[23]. However, these disorders have some common risks
such as exposure to difficult experience. These factors
cause stress in the patient, and prolonged stress leads to
cytokine secretion. Increased cytokines precipitate both
psychiatric diseases and increased pain perception
[26,27].
It is impossible to explain only one cause for FMS and
the etiopathogenesis of these disorders. In addition, the
relationship between concurrent disorders and FMS is
not clearly known.SNARE (soluble N-ethylmaleimide-sensitive factor ac-
tivating protein receptor) proteins have a role in fusion
between organelles, and organelles with plasma mem-
brane in eukaryotic cells. SNAP-25 is a SNARE protein
found in the plasma membrane. These proteins have im-
portant roles in electrical conduction in nerve cells.
Nerve transporters are found in synaptic vesicles and
sent by exocytosis to the other synapse. For this reason,
SNAP-25 affects dopamine and other neurotransmitter
secretions, and thus adds to FMS pathogenesis. There-
fore, SNARE like proteins should be studied carefully,
leading to better understanding of etiopathogenesis and
treatment approaches. Also, the relationship between
FMS and concurrent psychiatric disorders and personal-
ity features can be explained. For this purpose, we found
increased SNAP-25 Dde1 TC gene polymorphism in
FMS patients in this prospective study. In individuals
with the TC gene genotype, BDS and VAS scores were
found to be significantly higher than in individuals with-
out TC genotype. FMS is one of the central sensitization
syndromes. One mutual property of these diseases is that
neurons have increased stimulus mediated by several syn-
aptic and neurotransmitter/neurochemical activities with-
out structural pathology. This results in increased reaction
to basic stimuli. Patients who have the TC genotype have
increased BSD and VAS scores in our study, which can re-
sult from different affected neurotransmitter functions
both from this polymorphism and in pain transport. There
are no studies done in this matter, and our results should
be compared with similar studies.
The primary limitation of this study is trying to ex-
plain a complex disease such as FMS with only one
mutation with a small number of patients. With more
patients and other polymorphisms related to the disease,
it will help us understand FMS better in the future.Conclusions
FMS etiopathogenesis is not clearly known. Numerous
neurologic, cognitive and psychological disorders were
found during studies attempting to identify cause. Our
study showed increased SNAP-25 Ddel T/C genotype in
patients compared to controls, which is related with be-
havioral symptoms, personality and psychological disor-
ders in FMS patients.
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